Research Grants

Research & Scholarship

Research Grants - 2002

Total Grants Awarded for Year: $722,048
(derived from Grants and You, KCOM faculty and staff principal investigators are listed in bold font)

* Caldwell, Christopher T., D.O. (OMM), and Brian F. Degenhardt, D.O., Assistant Vice President for Osteopathic Research, Faculty Sponsor, (OMM). $5,000. August 1, 2002 - July 31, 2003. American Osteopathic Association. Patient-oriented Outcomes of Osteopathic Manipulative Treatment: An Epidemiologic Perspective.

Cenedella, Richard J., Ph.D., and Patricia Sexton, M.S. (Biochemistry). $226,250. National Institutes of Health. September 1, 2002 - August 31, 2003. Lens Cholesterol Metabolism and the U18666A Cataract—Year 25.

Cenedella, Richard J., Ph.D. (Biochemistry). $211,697. National Institutes of Health. June 1, 2002 - May 31, 2003. Lens Membrane Steroid Binding Protein (MSBP)—Year 03.

Darmani, Nissar A., Ph.D. (Pharmacology). $30,000. Solvay Pharmaceuticals. Nov. 1, 2002 - Oct. 31, 2003. Broad-Spectrum Antiemetic Actions of Ä9-THC-(Marinol).

Darmani, Nissar A., Ph.D. (Pharmacology). $15,000. Department of Defense. Sept. 27, 2002 - Apr. 30, 2003. Oral Exposure to Wildlife of Metals in Contaminated Soils.

* Darmani, Nissar A., Ph.D. (Pharmacology); Brian F. Degenhardt, D.O., Assistant Vice President for Osteopathic Research (OMM); Rene J. McGovern, Ph.D. (Neurobehavioral Sciences); Donald R. Noll, D.O., (Internal Medicine/Gerontology); G. Barry Robbins, Jr., D.O., Associate Dean for Regional Affairs (Internal Medicine); and Lex C. Towns, Ph.D. (Anatomy). $27,470. KCOM Strategic Research Initiative. July 1, 2002 - June 30, 2003. Investigation of Biochemical Markers for the Effect of OMT.

* Degenhardt, Brian F., D.O., Assistant Vice President for Osteopathic Research; Eric J. Snider, D.O., and Karen T. Snider, D.O. (OMM). $49,500. KCOM Strategic Research Initiative. July 1, 2002 - June 30, 2003. Developing Instrumentation for Objectifying Interexaminer Reliability.

Fleschner, C. R., Ph.D. (Biochemistry), and Melissa K. Stuart, Ph.D. (Microbiology/ Immunology). $4,000. KCOM Warner/Fermaturo Research Fund. July 1, 2002 - June 30, 2004. Isolation and Identification of Lens Plasma Membrane Domain Specific Proteins.

Geisbuhler, Timothy P., Ph.D. (Physiology). $4,000. KCOM Warner/Fermaturo Research Fund. July 1, 2002 - June 30, 2004. Effect of Sex Steroids on Anoxic Damage in Adult Cardiac Myocytes.

* Newton, Joseph P., D.O., and Brian F. Degenhardt, D.O., AVP for OR, Faculty Sponsor (OMM). $5,000. American Osteopathic Association Research Fellowship Program. September 1, 2002 - October 31, 2003. Evaluating the Efficacy of a Simple Osteopathic Treatment Approach in Dysmenorrhea.

* Noll, Donald R., D.O., FACOI, (Internal Medicine/Geriatrics); Robert W. Baer, Ph.D., and William L. Sexton, Ph.D. (Physiology); and Phillip C. Slocum, D.O., Associate Dean for Academic and Regional Affairs. $68,131. Osteopathic Heritage Foundation. November 11, 2002 - November 10, 2003. Immediate Changes in Pulmonary Function Parameters from Four Separate Osteopathic Manipulation Techniques in COPD.

Sargentini, Neil J., Ph.D. (Microbiology and Immunology), and Sam J. Pullen (Graduate Student). $5,000. KCOM Biomedical Sciences Program. October 10, 2002 - August 10, 2004. Characterization of the RadA/Sms DNA Repair Protein.

Sargentini, Neil J., Ph.D. (Microbiology and Immunology). $4,000. KCOM Warner/Fermaturo Research Fund. July 1, 2002 - June 30, 2004. Site-directed Mutagenesis of RadA Protein.

Sexton, William L., Ph.D. (Physiology). $55,000. American Heart Association-Heartland Affiliate. July 1, 2002 - June 30, 2003. Skeletal Muscle Microvascular PO2 and Diabetes-Year 10.

Sexton, William L., Ph.D. (Physiology), and Dion G. Miranda (Graduate Student). $5,000. KCOM Biomedical Sciences Program. April 1, 2002 - December 31, 2003. Impact of Aging and Exercise on Muscle PO2m Kinetics.

Stuart, Melissa K., Ph.D., and Neal R. Chamberlain, Ph.D. (Microbiology and Immunology). $2,000. KCOM Warner/Fermaturo Research Fund. July 1, 2002 - June 30, 2004. Monoclonal Antibodies to Elongation Factor-1 Alpha Inhibit Protein Translation In Vitro.

Stuart, Melissa K., Ph.D. (Microbiology and Immunology), and Theresa Murphy (Graduate Student). $5,000. KCOM Biomedical Sciences Program. May 1, 2002 - July 31, 2003. Characterization of Antibodies to Elongation Factor 1-alpha.

*Written by, or with, assistance from the Office of Grants and Program Development and/or the Office of Research Support.